scholarly journals Is Any Feature of the Stabilometric Evaluation Clinically Relevant in Patients with Temporomandibular Disorders? A Cross-Sectional Study

2021 ◽  
Vol 11 (10) ◽  
pp. 4473
Author(s):  
Raquel Delgado-Delgado ◽  
Juan Antonio Valera-Calero ◽  
Antonia Emma Gowie ◽  
Sofia Olivia Calvo-Moreno ◽  
María Belén Centenera-Centenera ◽  
...  

Current neuroanatomical evidence showed the anatomical relationship between the temporomandibular joint innervation with the vestibular system. However, there is no clear evidence regarding if temporomandibular disorders are associated with balance impairments. Therefore, the aims of this study were to assess the clinical relevance of stabilometric features in populations with temporomandibular disorders and to analyze the influence of the mandibular position and visual afference in the balance scores in both healthy and clinical populations. This observational study was conducted in one sample of healthy controls and one sample with temporomandibular disorders. Sociodemographic data (age, gender, height, weight, body mass index, and foot size), clinical data (presence or absence of temporomandibular disorders) and stabilometric data under six different conditions were collected. Sixty-nine subjects (43.5% male; 36.2% patients) were assessed. No differences between Temporomandibular disorders and healthy groups were found in any stabilometric outcomes, unlike oscillation area with closed eyes and medium interscuspidal position (p < 0.01). Although visual feedback showed to be relevant (p < 0.0001), mandibular position produced no differences in any stabilometric measurement (p > 0.05). This study found that healthy subjects and patients with temporomandibular disorders showed no balance differences in the stabilometric outcomes assessed. Although visual input played an important role in the balance, mandibular position seems to be irrelevant.

2017 ◽  
Vol 44 (5) ◽  
pp. 609-612 ◽  
Author(s):  
Marie-Alix Lanfranchi ◽  
Olivier Leluc ◽  
Alice Tavano ◽  
Cécile Wormser ◽  
Sophie Morange ◽  
...  

Objective.Enthesitis is the spondyloarthritis (SpA) landmark, but can also be seen after entheses overuse, such as during intensive sport.Methods.We aimed to compare entheses ultrasound (US) findings in a prospective cross-sectional study of 30 axial SpA cases, 30 athletes, and 29 controls.Results.Mean (SD) MAdrid Sonographic Enthesis Index (MASEI) score was 26.3 (13), 12.2 (7), and 10.4 (6) in patients with SpA, athletes, and non-athlete control groups, respectively (p < 0.0001).Conclusion.The MASEI score was significantly higher in patients with SpA compared with healthy controls, athletes, and non-athletes, and can be of value to distinguish SpA from healthy subjects, whatever their physical activity.


Rheumatology ◽  
2020 ◽  
Vol 59 (10) ◽  
pp. 2872-2880
Author(s):  
Xueshan Bai ◽  
Mingshu Sun ◽  
Yuwei He ◽  
Ruhua Liu ◽  
Lingling Cui ◽  
...  

Abstract Objectives Serum CA72-4 levels are elevated in some gout patients but this has not been comprehensively described. The present study profiled serum CA72-4 expression in gout patients and verified the hypothesis that CA72-4 is a predictor of future flares in a prospective gout cohort. Methods To profile CA72-4 expression, a cross-sectional study was conducted in subjects with gouty arthritis, asymptomatic hyperuricaemia, four major arthritis types (OA, RA, SpA, septic arthritis) and healthy controls. A prospective gout cohort study was initiated to test the value of CA72-4 for predicting gout flares. During a 6-month follow-up, gout flares, CA72-4 levels and other gout-related clinical variables were observed at 1, 3 and 6 months. Results CA72-4 was highly expressed in patients with gouty arthritis [median (interquartile range) 4.55 (1.56, 32.64) U/ml] compared with hyperuricaemia patients [1.47 (0.87, 3.29) U/ml], healthy subjects [1.59 (0.99, 3.39) U/ml] and other arthritis patients [septic arthritis, 1.38 (0.99, 2.66) U/ml; RA, 1.58 (0.95, 3.37) U/ml; SpA, 1.56 (0.98, 2.85) U/ml; OA, 1.54 (0.94, 3.34) U/ml; P &lt; 0.001, respectively]. Gout patients with frequent flares (twice or more in the last year) had higher CA72-4 levels than patients with fewer flares (fewer than twice in the last year). High CA72-4 level (&gt;6.9 U/ml) was the strongest predictor of gout flares (hazard ratio = 3.889). Prophylactic colchicine was effective, especially for patients with high CA72-4 levels (P = 0.014). Conclusion CA72-4 levels were upregulated in gout patients who experienced frequent flares and CA72-4 was a useful biomarker to predict future flares.


RSBO ◽  
2016 ◽  
Vol 13 (1) ◽  
pp. 25
Author(s):  
Glaucia Marques Dias ◽  
Letícia Ladeira Bonato ◽  
Patrícia Rocha Coelho ◽  
Josemar Parreira Guimarães ◽  
Rafaela Ladeira Bonato

Author(s):  
Elin Hadler‐Olsen ◽  
Elizabeth Thon ◽  
Gro Eirin Holde ◽  
Birgitta Jönsson ◽  
Nils Oscarson ◽  
...  

Pain Medicine ◽  
2021 ◽  
Author(s):  
Michal Rivel ◽  
Anat Achiron ◽  
Mark Dolev ◽  
Yael Stern ◽  
Gaby Zeilig ◽  
...  

Abstract Objective About a third of patients with multiple sclerosis (MS) suffer from chronic and excruciating central neuropathic pain (CNP). The mechanism underlying CNP in MS is not clear, since previous studies are scarce and their results are inconsistent. Our aim was to determine whether CNP in MS is associated with impairment of the spinothalamic-thalamocortical pathways (STTCs) and/or increased excitability of the pain system. Design Cross sectional study Setting General hospital Subjects 47 MS patients with CNP, 42 MS patients without CNP, and 32 healthy controls. Methods Sensory testing included the measurement of temperature, pain, and touch thresholds and the thermal grill illusion (TGI) for evaluating STTCs function, and hyperpathia and allodynia as indicators of hyperexcitability. CNP was characterized using interviews and questionnaires. Results The CNP group had higher cold and warm thresholds (p &lt; 0.01), as well as higher TGI perception thresholds (p &lt; 0.05), especially in painful body regions compared to controls, whereas touch and pain thresholds values were normal. The CNP group also had a significantly greater prevalence of hyperpathia and allodynia. Regression analysis revealed that whereas presence of CNP was associated with a higher cold threshold, CNP intensity, and the number of painful body regions were associated with allodynia and hyperpathia, respectively. Conclusions CNP in MS is characterized by a specific impairment of STTC function; the innocuous thermal pathways, and by pain hyperexcitability. Whereas CNP presence is associated with STTC impairment, its severity and extent are associated with pain hyperexcitability. Interventions that reduce excitability level may therefore mitigate CNP severity.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
R. Meier ◽  
C. Emch ◽  
C. Gross-Wolf ◽  
F. Pfeiffer ◽  
A. Meichtry ◽  
...  

Abstract Background Low back pain (LBP) is one of the most common musculoskeletal disorders, causing significant personal and social burden. Current research is focused on the processes of the central nervous system (particularly the sensorimotor system) and body perception, with a view to developing new and more efficient ways to treat chronic low back pain (CLBP). Several clinical tests have been suggested that might have the ability to detect alterations in the sensorimotor system. These include back-photo assessment (BPA), two-point discrimination (TPD), and the movement control tests (MCT). The aim of this study was to determine whether the simple clinical tests of BPA, TPD or MCT are able to discriminate between nonspecific CLBP subjects with altered body perception and healthy controls. Methods A cross-sectional study was conducted. At one point in time, 30 subjects with CLBP and 30 healthy controls were investigated through using BPA, TPD and MCT on the lower back. Correlations among the main covariates and odds ratios for group differences were calculated. Results MCT showed an odds ratio for the presence of CLBP of 1.92, with a statistically significant p-value (0.049) and 95%CI. The TPD and BPA tests were unable to determine significant differences between the groups. Conclusions Of the three tests investigated, MCT was found to be the only suitable assessment to discriminate between nonspecific CLBP subjects and healthy controls. The MCT can be recommended as a simple clinical tool to detect alterations in the sensorimotor system of nonspecific CLBP subjects. This could facilitate the development of tailored management strategies for this challenging LBP subgroup. However, further research is necessary to elucidate the potential of all the tests to detect alterations in the sensorimotor system of CLBP subjects. Trial registration No trial registration was needed as the study contains no intervention. The study was approved by the Swiss Ethics Commission of Northwest and Central Switzerland (EKNZ) reference number 2015–243.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Johanna Wallensten ◽  
Anna Nager ◽  
Marie Åsberg ◽  
Kristian Borg ◽  
Aniella Beser ◽  
...  

AbstractPatients with stress-induced exhaustion disorder (SED) demonstrate cognitive dysfunction similar to patients with minor traumatic brain injury (TBI). We have previously detected elevated concentrations of astrocyte-derived extracellular vesicles (EVs) in patients with TBI. As such, we hypothesized that astrocyte-derived EVs could be higher in patients with SED than in patients with major depressive disorder (MDD) and healthy controls. Patients with SED (n = 31), MDD (n = 31), and healthy matched controls (n = 61) were included. Astrocyte-derived EVs (previously known as microparticles) were measured in plasma with flow cytometry and labeled against glial fibrillary acidic protein (GFAP) and aquaporin 4 (AQP4). In addition, platelet EVs and their CD40 ligand expression were measured. Patients with SED had significantly higher concentrations of AQP4 and GFAP-positive EVs and EVs co-expressing AQP4/GFAP than patients with MDD and healthy controls. Patients with MDD had significantly higher concentrations of GFAP-positive EVs and EVs co-expressing AQP4/GFAP than healthy controls. Platelet EVs did not differ between groups. CD40 ligand expression was significantly higher in patients with SED and MDD than in controls. In conclusion, the present study suggests that patients with SED, and to some extent, patients with MDD, have increased leakage of astrocyte-derived EVs through the blood–brain barrier.


Sign in / Sign up

Export Citation Format

Share Document